Ken Fisher
AMPH icon

Ken Fisher’s Amphastar Pharmaceuticals AMPH Stock Holding History

Ken Fisher’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-58
Closed -$2.67K – 983
2023
Q3 		$2.67K Buy
+58
New +$3.16K ﹤0.01% 1132
2018
Q3 		– Sell
-130,468
Closed -$1.99M – 816
2018
Q2 		$1.99M Sell
130,468
-76,133
-37% -$1.33M ﹤0.01% 533
2018
Q1 		$3.87M Sell
206,601
-22,676
-10% -$426K 0.01% 459
2017
Q4 		$4.41M Buy
229,277
+17,094
+8% +$319K 0.01% 438
2017
Q3 		$3.79M Buy
212,183
+16,636
+9% +$274K 0.01% 431
2017
Q2 		$3.49M Buy
195,547
+44,492
+29% +$706K 0.01% 416
2017
Q1 		$2.19M Buy
151,055
+51,731
+52% +$813K ﹤0.01% 429
2016
Q4 		$1.83M Sell
99,324
-98,334
-50% -$1.91M ﹤0.01% 431
2016
Q3 		$3.75M Sell
197,658
-52,673
-21% -$956K 0.01% 379
2016
Q2 		$4.24M Sell
250,331
-26,141
-9% -$369K 0.01% 366
2016
Q1 		$3.52M Hold
276,472
– – 0.01% 389
2015
Q4 		$3.93M Buy
276,472
+44,610
+19% +$589K 0.01% 372
2015
Q3 		$2.71M Buy
+231,862
New +$3.48M 0.01% 411

Other funds holding AMPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return

Ken Fisher's AMPH Position: Q4 2023 in Review

Ken Fisher sold out of Amphastar Pharmaceuticals (AMPH) in Q4 2023, closing a stake of 58 shares — an estimated $2.67K sold.

Ken Fisher first reported a position in AMPH in Q3 2015 and held it in 13 quarters. The position peaked at $4.41M in Q4 2017. 277 funds tracked by Wall St. Rank hold AMPH as of Q4 2023.

  • Ken Fisher reported no remaining Amphastar Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
  • Ken Fisher sold 58 Amphastar Pharmaceuticals shares in Q4 2023, an estimated $2.67K.
  • Ken Fisher first reported a position in Amphastar Pharmaceuticals in Q3 2015 and held it in 13 quarters.
  • Ken Fisher's Amphastar Pharmaceuticals position peaked at $4.41M in Q4 2017.
  • 277 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q4 2023.

Based on Fisher Asset Management's 13F filing for Q4 2023, filed 6 Feb 2024.